These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 19560734)

  • 1. Molecular epigenetics and genetics in neuro-oncology.
    Nagarajan RP; Costello JF
    Neurotherapeutics; 2009 Jul; 6(3):436-46. PubMed ID: 19560734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic aberrations and therapeutic implications in gliomas.
    Natsume A; Kondo Y; Ito M; Motomura K; Wakabayashi T; Yoshida J
    Cancer Sci; 2010 Jun; 101(6):1331-6. PubMed ID: 20384628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene regulation by methylation.
    Mueller WC; von Deimling A
    Recent Results Cancer Res; 2009; 171():217-39. PubMed ID: 19322547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
    Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
    J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y; Wong CW; Chirieac LR; Kondo Y; Shen L; Webb CR; Chan YW; Chan AS; Chan TL; Wu TT; Rashid A; Hamanaka Y; Hinoda Y; Shannon RL; Wang X; Morris J; Issa JP; Yuen ST; Leung SY; Hamilton SR
    Clin Cancer Res; 2008 May; 14(9):2560-9. PubMed ID: 18451217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.
    Gömöri E; Pál J; Kovács B; Dóczi T
    Diagn Pathol; 2012 Jan; 7():8. PubMed ID: 22264301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors.
    Kuo LT; Kuo KT; Lee MJ; Wei CC; Scaravilli F; Tsai JC; Tseng HM; Kuo MF; Tu YK
    Int J Cancer; 2009 Jun; 124(12):2872-9. PubMed ID: 19330828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Space of
    Ibrahim Al-Obaide MA; Arutla V; Bacolod MD; Wang W; Zhang R; Srivenugopal KS
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive biomarkers in adult gliomas: the present and the future.
    Thomas L; Di Stefano AL; Ducray F
    Curr Opin Oncol; 2013 Nov; 25(6):689-94. PubMed ID: 24076583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations.
    Ramalho-Carvalho J; Pires M; Lisboa S; Graça I; Rocha P; Barros-Silva JD; Savva-Bordalo J; Maurício J; Resende M; Teixeira MR; Honavar M; Henrique R; Jerónimo C
    PLoS One; 2013; 8(3):e58206. PubMed ID: 23505468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
    Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
    BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic changes in gliomas.
    Burgess R; Jenkins R; Zhang Z
    Cancer Biol Ther; 2008 Sep; 7(9):1326-34. PubMed ID: 18836290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of four or more CpGs methylation present equivalent predictive value for MGMT expression and temozolomide therapeutic prognosis in gliomas.
    Chai RC; Zhang KN; Liu YQ; Wu F; Zhao Z; Wang KY; Jiang T; Wang YZ
    CNS Neurosci Ther; 2019 Mar; 25(3):314-322. PubMed ID: 30117294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas.
    Oldrini B; Vaquero-Siguero N; Mu Q; Kroon P; Zhang Y; Galán-Ganga M; Bao Z; Wang Z; Liu H; Sa JK; Zhao J; Kim H; Rodriguez-Perales S; Nam DH; Verhaak RGW; Rabadan R; Jiang T; Wang J; Squatrito M
    Nat Commun; 2020 Aug; 11(1):3883. PubMed ID: 32753598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
    Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
    Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial.
    Collins VP; Ichimura K; Di Y; Pearson D; Chan R; Thompson LC; Gabe R; Brada M; Stenning SP;
    Acta Neuropathol Commun; 2014 Jun; 2():68. PubMed ID: 24952577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MGMT testing--the challenges for biomarker-based glioma treatment.
    Wick W; Weller M; van den Bent M; Sanson M; Weiler M; von Deimling A; Plass C; Hegi M; Platten M; Reifenberger G
    Nat Rev Neurol; 2014 Jul; 10(7):372-85. PubMed ID: 24912512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.